Skip to main content
Top
Published in: Clinical Rheumatology 9/2007

01-09-2007 | Case Report

Hypernatremic myopathy caused by a hypothalamic mixed germ cell tumor mimicking polymyositis

Authors: Min-Nung Huang, Jien-Jiun Chen, Kuang-Lun Lee, Fen-Yu Tseng, Chia-Li Yu, Song-Chou Hsieh

Published in: Clinical Rheumatology | Issue 9/2007

Login to get access

Abstract

Hypernatremic myopathy was rarely reported in the literature and its clinical features have never been well-described. We present a 22-year-old man who had adipsic hypernatremia manifested with progressive proximal muscle weakness and remarkably high creatine kinase level that has never been reported in the cases of hypernatremic myopathy. His initial presentations were similar to that of polymyositis without the evidence of central nervous system dysfunction and hypopituitarism. The serum level of sodium at the beginning of myopathy is the lowest known in the literature. All the clinical presentations in this patient resulted from a hypothalamic mixed germ cell tumor with sub-acute intra-tumoral hemorrhage.
Literature
1.
3.
4.
go back to reference Hiromatsu K, Kobayashi T, Fujii N, Itoyama Y, Goto I, Murakami J (1994) Hypernatremic myopathy. J Neurol Sci 122:144–147PubMedCrossRef Hiromatsu K, Kobayashi T, Fujii N, Itoyama Y, Goto I, Murakami J (1994) Hypernatremic myopathy. J Neurol Sci 122:144–147PubMedCrossRef
5.
go back to reference Pleasure D, Goldberg M (1966) Neurogenic hypernatremia. Arch Neurol 15:78–87PubMed Pleasure D, Goldberg M (1966) Neurogenic hypernatremia. Arch Neurol 15:78–87PubMed
6.
go back to reference Alford FP, Scoggins BA (1973) Symptomatic normovolemic essential hypernatremia. A clinical and physiologic study. Am J Med 54:359–370PubMedCrossRef Alford FP, Scoggins BA (1973) Symptomatic normovolemic essential hypernatremia. A clinical and physiologic study. Am J Med 54:359–370PubMedCrossRef
7.
go back to reference Kastin AJ, Lipsett MB, Ommaya AK, Moser JM Jr (1965) Asymptomatic hypernatremia: physiological and clinical study. Am J Med 38:306–315PubMedCrossRef Kastin AJ, Lipsett MB, Ommaya AK, Moser JM Jr (1965) Asymptomatic hypernatremia: physiological and clinical study. Am J Med 38:306–315PubMedCrossRef
8.
go back to reference Maddy JA, Winternitz WW (1971) Hypothalamic syndrome with hypernatremia and muscular paralysis. Am J Med 51:394–402PubMedCrossRef Maddy JA, Winternitz WW (1971) Hypothalamic syndrome with hypernatremia and muscular paralysis. Am J Med 51:394–402PubMedCrossRef
9.
go back to reference Komatsu H, Miyake H, Kakita S, Ikuta H (2001) Hypoplasia of the corpus callosum associated with adipsic hypernatremia and hypothalamic hypogonadotropinism: a case report and review of the literature. Pediatr Int 43:683–687PubMedCrossRef Komatsu H, Miyake H, Kakita S, Ikuta H (2001) Hypoplasia of the corpus callosum associated with adipsic hypernatremia and hypothalamic hypogonadotropinism: a case report and review of the literature. Pediatr Int 43:683–687PubMedCrossRef
10.
go back to reference Robertson GL (2001) Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am 30:671–94PubMedCrossRef Robertson GL (2001) Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am 30:671–94PubMedCrossRef
13.
go back to reference Shinoda J, Sakai N, Yano H, Hattori T, Ohkuma A, Sakaguchi H (2004) Prognostic factors and therapeutic problems of primary intracranial choriocarcinoma/germ-cell tumors with high levels of HCG. J Neurooncol 66:225–240PubMedCrossRef Shinoda J, Sakai N, Yano H, Hattori T, Ohkuma A, Sakaguchi H (2004) Prognostic factors and therapeutic problems of primary intracranial choriocarcinoma/germ-cell tumors with high levels of HCG. J Neurooncol 66:225–240PubMedCrossRef
14.
15.
go back to reference Cannon PR, Frazier LE, Hughes RH (1953) Sodium as a toxic ion in potassium deficiency. Metabolism 2:297–312PubMed Cannon PR, Frazier LE, Hughes RH (1953) Sodium as a toxic ion in potassium deficiency. Metabolism 2:297–312PubMed
Metadata
Title
Hypernatremic myopathy caused by a hypothalamic mixed germ cell tumor mimicking polymyositis
Authors
Min-Nung Huang
Jien-Jiun Chen
Kuang-Lun Lee
Fen-Yu Tseng
Chia-Li Yu
Song-Chou Hsieh
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0481-1

Other articles of this Issue 9/2007

Clinical Rheumatology 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.